EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Cyto toxic effect of lymphocytes from pregnant mice on cultivated tumor cells part 1 specificity nature of effector cells and blocking by serum



Cyto toxic effect of lymphocytes from pregnant mice on cultivated tumor cells part 1 specificity nature of effector cells and blocking by serum



International Journal of Cancer 15(1): 1-16




(PDF emailed within 1 workday: $29.90)

Accession: 026358776

Download citation: RISBibTeXText



Related references

Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum. International Journal of Cancer 15(1): 1-16, 1975

Cyto toxic effect of lymphocytes from pregnant mice on cultivated tumor cells part 2 blocking and unblocking of cyto toxicity. International Journal of Cancer 15(1): 30-38, 1975

Lymphocyte mediated cyto toxicity against tumor cells part 1 concanavalin a activated cyto toxic effector cells exhibit immunological specificity. Cellular Immunology 17(2): 392-404, 1975

Lymphocyte mediated cyto toxicity against allogeneic tumor cells 4. fine specificity mapping and characterization of concanavalin a activated cyto toxic effector lymphocytes. Immunology 44(4): 685-694, 1981

Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. II. Blocking and unblocking of cytotoxicity. International Journal of Cancer 15(1): 30-38, 1975

Effect of tumor cells on the generation of cyto toxic thymus derived lymphocytes in vitro part 1 accessory cell functions of mouse tumor cells in the generation of cyto toxic thymus derived lymphocytes in vitro replacement of adherent phagocytic cells by tumor cells or 2 mercapto ethanol. European Journal of Immunology 7(6): 394-400, 1977

Generation of cyto toxic lymphocytes in mixed lymphocyte reactions part 1 specificity of the effector cells. Journal of Experimental Medicine 138(3): 672-685, 1973

Cyto toxic immune cells with specificity for defined soluble antigens part 5 interaction of antibody with the cyto toxic effector cells in immune or nonimmune mouse spleen cells. Journal of Immunology 112(6): 2219-2226, 1974

Secondary cyto toxic cell response to lymphocytic choriomeningitis virus part 2 nature and specificity of effector cells. Immunology 31(2): 181-186, 1976

Lymphocyte mediated cyto toxicity against tumor cells part 3 differentiation of concanavalin a activated cyto toxic effector cells. European Journal of Immunology 6(5): 317-320, 1976

Lymphocyte mediated cyto toxicity against tumor cells part 2 characteristics and tissue distribution of concanavalin a activated cyto toxic effector cells. European Journal of Immunology 6(5): 309-316, 1976

Cyto toxic lymphocytes part 2 antagonism and synergism between serum factors and lymphocytes of patients with sarcomas as tested against cultured tumor cells. Texas Reports on Biology & Medicine 30(4): 347-360, 1972

Cyto toxic thymus derived lymphocytes to murine plasma cytoma cells in allogeneic and syngeneic mice h 2 antigens are essential in the induction and effector stages of cyto toxic thymus derived lymphocytes. Journal of Immunology 121(2): 427-437, 1978

Fine specificity of cyto toxic thymus derived lymphocytes c 57bl effector cells induced by autologous cells modified with hapten 4 hydroxy 3 nitrophenyl acetyl are not heteroclitic. European Journal of Immunology 9(3): 211-213, 1979

Specific anti tumor responses of cultured immune spleen cells part 3 further characterization of cells which synthesize factors with blocking and anti serum dependent cellular cyto toxic activities. International Journal of Cancer 16(4): 539-549, 1975